HealthEquity (NASDAQ:HQY) Releases FY 2027 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY 2027 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.660-4.730 for the period, compared to the consensus EPS estimate of 4.560. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Analyst Ratings Changes

Several research analysts have recently commented on HQY shares. Citizens Jmp lifted their price target on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a report on Monday, June 1st. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, August 22nd. Finally, BTIG Research raised their price target on shares of HealthEquity from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Friday, July 24th. Eleven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

HealthEquity Stock Down 0.9%

Shares of NASDAQ:HQY opened at $104.42 on Thursday. The company has a market capitalization of $8.73 billion, a price-to-earnings ratio of 39.11, a PEG ratio of 1.77 and a beta of 0.21. HealthEquity has a 12-month low of $72.76 and a 12-month high of $107.62. The business has a 50-day moving average price of $97.77 and a 200 day moving average price of $87.71. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. The company had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Sell-side analysts expect that HealthEquity will post 3.92 EPS for the current year.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 7,966 shares of company stock worth $756,770. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Acumen Wealth Advisors LLC acquired a new position in HealthEquity during the 4th quarter worth about $27,000. Aster Capital Management DIFC Ltd purchased a new stake in HealthEquity during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd increased its stake in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in shares of HealthEquity by 190.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock worth $55,000 after purchasing an additional 396 shares in the last quarter. Finally, Larson Financial Group LLC boosted its stake in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.